
Sign up to save your podcasts
Or


Voraxapar and Atopaxar - Mechanism of action and therapeutic uses
Cilostazol - Mechanism of action, therapeutic uses, and drug interactions
GP IIb/IIIa inhibitors - Abciximab, Tirofiban, Eptifibatide - Mechanism of action, therapeutic uses, and adverse effects
Adenosine diphosphate antagonists - Clopidogrel, Ticlopidine, Prasugrel, Ticagrelor, Cangrelor - Mechanism of action, therapeutic uses, and adverse effects
Classification of antiplatelet drugs - COX inhibitors such as aspirin, ADP antagonist such as Clopidogrel, Ticlopidine, Prasugrel, GP IIb/IIIa antagonist-Abciximab, Eptifibatide, Tirobifan, PDE inhibitors such as Dipyridamole, PAR antagonists such as voraxapar and atopaxar
Thromboembolic disorders - Platelets, Clotting factors, Fibrinolysis - Deep vein thrombosis, Myocardial infarction, Pulmonary embolism, and Stroke
Class V antiarrhythmic drugs - Adenosine, Digoxin, and Magnesium sulfate - antiarrhythmic uses and their adverse effects
Class IV antiarrhythmic drugs - Diltiazem and Verapamil antiarrhythmic mechanism and uses
From the publisher's feed